Jay T. Backstrom Acceleron Pharma Inc (XLRN) insider trading activity

XLRN Quotes by TradingView
Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held N/A

Jay T. Backstrom Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Disposition due to a tender of shares in a change of control transaction
-
21,233 Reduced 100.0%
0 Common Stock
Jan 29 2021
BUY
Grant, award, or other acquisition
-
5,409 Added 20.65%
20,781 Common Stock
Jan 04 2021
SELL
Payment of exercise price or tax liability
$215,678 $124.31 p/Share
1,735 Reduced 10.14%
15,372 Common Stock

Also insider at

SRRK
Scholar Rock Holding Corp Healthcare
CHIEF EXECUTIVE OFFICER
GMTX
Gemini Therapeutics, Inc. Healthcare
Director
JTB

Jay T. Backstrom

EVP, Research and Development
Cambridge, MA

Track Institutional and Insider Activities on XLRN

Follow ACCELERON PHARMA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLRN shares.

Notify only if

Insider Trading

Get notified when an Acceleron Pharma Inc insider buys or sells XLRN shares.

Notify only if

News

Receive news related to ACCELERON PHARMA INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XLRN